Drawing for PHENOSTICS

USPTO serial 78337120

PHENOSTICS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
BUONGIORNO, CHRISTOPHER L
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PHENOSTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Catherine Mennenga

CATHERINE MENNENGA GENERAL ELECTRIC COMPANY3135 EASTON TPKEFAIRFIELD, CT 06828-0001UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemicals and chemical reagents for use in industry, science and research; biochemical and biological preparations for use in industry, science and research; chemical preparations for scientific purposes; preparations for diagnosis for scientific purposes; radioactive elements, isotopes, preparations and reagents for industrial, research and scientific purposes; gases and gas mixtures for industrial, research and scientific purposesACTIVE—
005Diagnostic agents, preparations and substances for medical diagnostic purposes; Contrast media for medical imaging; diagnostic scanning agents for in vivo use; radiopharmaceutical products for clinical, medical and research use; radioactive sources and standards for use in nuclear medicine; radioactive pharmaceutical preparations and non-radioactive reagents for producing radiopharmaceuticals for in vivo diagnostic or therapeutic use; pharmaceutical preparations for use in diagnosis; pre-filled vials and cartridges containing medical diagnostic reagents or saline solution; radioisotope brachytherapy substances; and gases and gas mixtures for medical imagingACTIVE—
009Scientific apparatus and instruments used for radiology for the purpose of measuring, monitoring and surveying; computers, printers, and software programs used for the purpose of life science research and for nuclear cardiology and medical imaging, for use by laboratories, pharmacies, doctors, hospitals, and medical service providers; radiology apparatus and instruments for the reading and interpretation of autoradiographs and films, namely automated film readers and scanners; apparatus for electrophoresis; chromatography columns and pumps; apparatus for microfabrication; apparatus for scintillation; imaging apparatus for radioactive and luminescent emissions; synthesis and purification integrated systems for use in radiology; apparatus for manufacturing oligonucleotides; apparatus for microarrays; microarray slides; laboratory glassware; laboratory vials and microvials; microtitre plates; and parts and fittings for the aforesaid goodsACTIVE—
010Surgical, medical, dental, and veterinary apparatus and instruments used for the purpose of measuring, monitoring and surveying in the field of radiotherapy, comprised of medical needles, suture needles, implantable radiation therapy devices consisting of encapsulated radioisotope brachytherapy sources, radiation therapy delivery system consisting primarily of radioactive seeds and a bio-absorbable carrier assembly; magnetic resonance imagers, MRI; x-ray apparatus for medical use; x-ray diagnostic apparatus, computerized tomography, CAT scanners and ultrasound imagers; radiological apparatus for diagnostic and medical purposes; diagnostic and test kits for clinical medical use comprised of test tubes, test plates and indicator charts for evaluating test results; vials; cannulas; needles and syringes; injectors; cartridges; infusion pumps for intravenous administration of fluids; needles for medical purposes; and parts and fittings for the aforesaid goodsACTIVE—
042Advisory services for pharmaceutical companies in the field of purification and chromatography; research and development services in the field of pharmaceutical and life sciences, high through put screening assays for drug development services; research and product development for others, namely, research and development of pharmaceutical, medical, and veterinary preparations, diagnostic media and agents for use in medical and diagnostic imaging; consultancy services relating to chemical and pharmaceutical research; analytical services in the fields of medicine, pharmaceuticals and biochemistry; radiolabeling services, namely isotopic labeling of biological molecules; pharmaceutical drug development services for pharmaceutical companies and medical professionalsACTIVE—
044Medical diagnostic services; medical imaging services; providing medical information to pharmaceutical companies and medical professionalsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Oct 11, 2006MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 11, 2006ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 7, 2006NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 15, 2005PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 26, 2005NPUBNOTICE OF PUBLICATION—
Sep 20, 2005PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Sep 16, 2005ALIEASSIGNED TO LIE—
Sep 12, 2005CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 12, 2005GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 12, 2005CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 12, 2005ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Sep 6, 2005PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Aug 11, 2005PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Aug 5, 2005ALIEASSIGNED TO LIE—
Aug 3, 2005CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 2, 2005GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 2, 2005CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 14, 2005ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 14, 2005REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jan 4, 2005GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 4, 2005CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Dec 10, 2004ACECAMENDMENT FROM APPLICANT ENTERED—
Nov 22, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 22, 2004MAILPAPER RECEIVED—
Jul 15, 2004GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 29, 2004DOCKASSIGNED TO EXAMINER—
Dec 31, 2003NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance